Novartis AG (NVS) annual results, year to 31 December 2024: revenue USD 50,317 million, from the 20-F
Novartis AG files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2024 it reported revenue from the sale of goods of USD 50,317 million, up 10.7% on the year before. Its profit attributable to shareholders was USD 11,941 million, down 19.6%, and diluted earnings per share USD 5.87.
this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.
Income statement (profit and loss)
| Year to | Dec 2023 | Dec 2024 |
|---|---|---|
| Revenue from the sale of goods | 45,440 | 50,317 |
| Cost of sales | 12,472 | 12,827 |
| Gross profit | 34,188 | 38,895 |
| Research and development | 11,371 | 10,022 |
| Selling, general and administrative | 12,517 | 12,566 |
| Operating profit | 9,769 | 14,544 |
| Profit before tax | 9,123 | 13,640 |
| Income tax | 551 | 1,701 |
| Profit for the year | 14,854 | 11,939 |
| Profit attributable to shareholders | 14,850 | 11,941 |
| Filing | 20-F | 20-F |
Read more
A line the company does not file under the standard tag is left out rather than estimated.USD per ordinary share, as filed.
Cash flow
| Year to | Dec 2023 | Dec 2024 |
|---|---|---|
| Cash from operations | 14,458 | 17,619 |
| Purchase of property, plant and equipment | 1,060 | 1,366 |
| Free cash flow | 13,398 | 16,253 |
| Cash from investing | 5,596 | -7,513 |
| Cash from financing | -14,278 | -11,742 |
| Buybacks | 8,719 | 8,331 |
| Dividends paid | 7,255 | 7,624 |
| Filing | 20-F | 20-F |
USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.
Balance sheet
| Year to | Dec 2023 | Dec 2024 |
|---|---|---|
| Funded by | ||
| Equity attributable to shareholders | 46,667 | 44,046 |
| Non-controlling interests | 83.0 | 80.0 |
| Borrowings, as filed | 20,627 | 24,722 |
| Lease liabilities | 1,828 | 1,803 |
| Other liabilities | 30,740 | 31,595 |
| Total equity and liabilities | 99,945 | 102,246 |
| Owned | ||
| Property, plant and equipment | 9,514 | 9,458 |
| Goodwill | 23,341 | 24,756 |
| Other intangible assets | 26,879 | 26,915 |
| Cash and cash equivalents | 13,393 | 11,459 |
| Inventories | 5,913 | 5,723 |
| Other assets | 20,905 | 23,935 |
| Total assets | 99,945 | 102,246 |
| Filing | 20-F | 20-F |
USD million, at each fiscal year end.
Ratios on the filed lines
Arithmetic on the filed lines of the same year.
20-F for the year to 31 December 2024, filed 4 February 2026: the filing. The figures are in US dollars as filed.